Pseudocedrela kotschyi limits airway inflammation in ovalbumin-induced asthma in guinea pigs

Asthma is a respiratory disorder characterized by chronic airway inflammation, bronchial hyper-responsiveness and airflow obstruction. Its prevalence and associated mortality is expected to rise in the coming years particularly in Sub-Saharan Africa. This, together with cost and access limitations t...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Aaron Opoku Antwi, Edmund Ekuadzi, Eric Boakye-Gyasi, Ohui Nyadubea Agbettor, Christabelle Awurakua Opare, Rodney Atobrah, Rita Akosua Dickson
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Include these here if the journal requires them Science Q
Acceso en línea:	https://doaj.org/article/36f2c19b4f104abe82b1f22a66805836
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:36f2c19b4f104abe82b1f22a66805836
record_format	dspace
spelling	oai:doaj.org-article:36f2c19b4f104abe82b1f22a668058362021-11-14T04:34:47ZPseudocedrela kotschyi limits airway inflammation in ovalbumin-induced asthma in guinea pigs2468-227610.1016/j.sciaf.2021.e01023https://doaj.org/article/36f2c19b4f104abe82b1f22a668058362021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2468227621003240https://doaj.org/toc/2468-2276Asthma is a respiratory disorder characterized by chronic airway inflammation, bronchial hyper-responsiveness and airflow obstruction. Its prevalence and associated mortality is expected to rise in the coming years particularly in Sub-Saharan Africa. This, together with cost and access limitations to effective disease management has highlighted the need to explore potentially effective, indigenous therapeutic alternatives. Our study set out to evaluate the effect of Pseudocedrela. kotschyi bark extract (PKE), a traditionally used remedy, on airway hyper-responsiveness and airway inflammation associated with ovalbumin-induced asthma in guinea pigs. We focused on the protective effect of PKE treatment on antigen-provoked hyper-responsiveness, inflammatory cell proliferation and structural changes in lung tissue associated with chronic asthma. Our investigations showed that PKE at 50, 100 and 500 mg/kg delayed onset of peak respiratory distress in asthmatic guinea pigs by 38.46 ± 8.88%, 61.54 ± 14.73%, 69.23 ± 8.88% respectively, relative to saline-treated group. Bronchoalveolar lavage fluid (BALF) analysis revealed significant suppression of eosinophil and total leucocyte proliferation associated with ovalbumin-induced asthma, in PKE-treated guinea pigs. Lung sections of PKE-treated guinea pigs showed a markedly preserved architecture with less severe bronchial smooth muscle hypertrophy, peri‑bronchiolar and alveolar inflammatory cell infiltration compared with saline-treated guinea pigs. Our findings therefore demonstrate that P. kotschyi is effective in reducing key features of experimentally induced chronic asthma and support its traditional use in the management of asthma.Aaron Opoku AntwiEdmund EkuadziEric Boakye-GyasiOhui Nyadubea AgbettorChristabelle Awurakua OpareRodney AtobrahRita Akosua DicksonElsevierarticleInclude these here if the journal requires themScienceQENScientific African, Vol 14, Iss , Pp e01023- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Include these here if the journal requires them Science Q
spellingShingle	Include these here if the journal requires them Science Q Aaron Opoku Antwi Edmund Ekuadzi Eric Boakye-Gyasi Ohui Nyadubea Agbettor Christabelle Awurakua Opare Rodney Atobrah Rita Akosua Dickson Pseudocedrela kotschyi limits airway inflammation in ovalbumin-induced asthma in guinea pigs
description	Asthma is a respiratory disorder characterized by chronic airway inflammation, bronchial hyper-responsiveness and airflow obstruction. Its prevalence and associated mortality is expected to rise in the coming years particularly in Sub-Saharan Africa. This, together with cost and access limitations to effective disease management has highlighted the need to explore potentially effective, indigenous therapeutic alternatives. Our study set out to evaluate the effect of Pseudocedrela. kotschyi bark extract (PKE), a traditionally used remedy, on airway hyper-responsiveness and airway inflammation associated with ovalbumin-induced asthma in guinea pigs. We focused on the protective effect of PKE treatment on antigen-provoked hyper-responsiveness, inflammatory cell proliferation and structural changes in lung tissue associated with chronic asthma. Our investigations showed that PKE at 50, 100 and 500 mg/kg delayed onset of peak respiratory distress in asthmatic guinea pigs by 38.46 ± 8.88%, 61.54 ± 14.73%, 69.23 ± 8.88% respectively, relative to saline-treated group. Bronchoalveolar lavage fluid (BALF) analysis revealed significant suppression of eosinophil and total leucocyte proliferation associated with ovalbumin-induced asthma, in PKE-treated guinea pigs. Lung sections of PKE-treated guinea pigs showed a markedly preserved architecture with less severe bronchial smooth muscle hypertrophy, peri‑bronchiolar and alveolar inflammatory cell infiltration compared with saline-treated guinea pigs. Our findings therefore demonstrate that P. kotschyi is effective in reducing key features of experimentally induced chronic asthma and support its traditional use in the management of asthma.
format	article
author	Aaron Opoku Antwi Edmund Ekuadzi Eric Boakye-Gyasi Ohui Nyadubea Agbettor Christabelle Awurakua Opare Rodney Atobrah Rita Akosua Dickson
author_facet	Aaron Opoku Antwi Edmund Ekuadzi Eric Boakye-Gyasi Ohui Nyadubea Agbettor Christabelle Awurakua Opare Rodney Atobrah Rita Akosua Dickson
author_sort	Aaron Opoku Antwi
title	Pseudocedrela kotschyi limits airway inflammation in ovalbumin-induced asthma in guinea pigs
title_short	Pseudocedrela kotschyi limits airway inflammation in ovalbumin-induced asthma in guinea pigs
title_full	Pseudocedrela kotschyi limits airway inflammation in ovalbumin-induced asthma in guinea pigs
title_fullStr	Pseudocedrela kotschyi limits airway inflammation in ovalbumin-induced asthma in guinea pigs
title_full_unstemmed	Pseudocedrela kotschyi limits airway inflammation in ovalbumin-induced asthma in guinea pigs
title_sort	pseudocedrela kotschyi limits airway inflammation in ovalbumin-induced asthma in guinea pigs
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/36f2c19b4f104abe82b1f22a66805836
work_keys_str_mv	AT aaronopokuantwi pseudocedrelakotschyilimitsairwayinflammationinovalbumininducedasthmainguineapigs AT edmundekuadzi pseudocedrelakotschyilimitsairwayinflammationinovalbumininducedasthmainguineapigs AT ericboakyegyasi pseudocedrelakotschyilimitsairwayinflammationinovalbumininducedasthmainguineapigs AT ohuinyadubeaagbettor pseudocedrelakotschyilimitsairwayinflammationinovalbumininducedasthmainguineapigs AT christabelleawurakuaopare pseudocedrelakotschyilimitsairwayinflammationinovalbumininducedasthmainguineapigs AT rodneyatobrah pseudocedrelakotschyilimitsairwayinflammationinovalbumininducedasthmainguineapigs AT ritaakosuadickson pseudocedrelakotschyilimitsairwayinflammationinovalbumininducedasthmainguineapigs
_version_	1718429890132312064

Pseudocedrela kotschyi limits airway inflammation in ovalbumin-induced asthma in guinea pigs

Ejemplares similares